Trade U.S., Hong Kong, Japanese, and South Korean stocks directly. Selected U.S., Hong Kong, and South Korean stocks support 24/7 trading. You hold actual shares. Corporate actions such as dividends and stock splits are handled according to market rules.
Content updated: 2026-11-22 22:22:02
- Yesterday's Close
- $82.55
- Today's Open
- $82.80
- Today's High
- $82.80
- Today's Low
- $79.95
- Volume
- 709.97K shares
- 52-Week Range
- $79.50-$124.00
As of 2026-11-22 22:22:02, BioNTech (BNTX) was quoted at $80.76, a change of -$1.79 (-2.16%) from the previous close. The day's range was $79.95–$82.80, and the 52-week range was $79.50–$124.00.
Why Is BioNTech (BNTX) Stock Falling?
AI Stock Price AnalysisContent updated: 2026-11-20 21:53:27
BNTX opened lower, spiked to $82.86, then gave back the gain and settled near volume-weighted average price (VWAP), down 0.45% to $80.97 on volume near 1.59x baseline. The Nov 17 priority review voucher purchase remains the latest verifiable company news.
About BioNTech (BNTX)
- Ticker / Exchanges
- BNTX / NASDAQ
- Industry / Sector
- Biotechnology / Healthcare
- CEO
- Ugur Sahin
- Headquarters
- Mainz,RP,DE
- Official Website
- https://www.biontech.com/de/de/home.html
- Listing Date
- 2019-10-10
Recent Company Events
- 2026-11-03Earnings Report · ReleasedThe 2026/Q3 earnings report has been released.
BioNTech (BNTX) Derivatives Trading
Trade stock price movements through CFDs without holding the underlying shares. CFDs support long and short positions and leveraged trading. Be aware of spreads, trading fees, overnight fees, and liquidation risk.
BioNTech (BNTX) Company Financials
Valuation and Shares
- Market Cap
- $20.07B
- P/E Ratio (TTM)
- -12.55
- P/B Ratio
- 1.03
- Shares Outstanding
- 247.92M shares
- Float Shares
- 106.00M shares
- Dividend Yield (TTM)
- 0.00%
Latest Reported Financials
2026 Q3 FinancialsReport Release Date: 2026-11-03
Operating Revenue (Actual)
$1.60B
Same Period Last Year: -17.91%
Earnings per Share (Actual)
$0.90
Same Period Last Year: +690.71%
Financials · Actuals
| Actual Value | 2022/Annual | 2023/Annual | 2024/Annual | 2025/Annual |
|---|---|---|---|---|
| Revenue | $18.99B | $4.19B | $3.01B | $3.14B |
| Net Profit | $10.35B | $1.02B | -$729.72M | -$1.24B |
| Operating Cash Flow | $14.89B | $5.89B | $228.24M | $500.38M |
BNTX FAQ
What is the current stock price of BioNTech (BNTX)?
Which exchange is BNTX listed on?
How has BioNTech stock performed over the past month?
What is the market cap of BioNTech?
What are BioNTech's latest financial results?
What factors may affect the stock price of BioNTech (BNTX)?
Risk Warning
Disclaimer






